Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Data Analysis and Real World Interrogation Network (DARWIN EU)

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 14 September 2026 to 18 September 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 12 October 2026 to 16 October 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 9 November 2026 to 13 November 2026

Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, European Medicines Agency, Amsterdam, the Netherlands, from 7 December 2026 to 11 December 2026

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 4-6 May 2026

Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Date of authorisation: 27/04/2026, Status: Authorised